Page 401 - Veterinary Immunology, 10th Edition
P. 401

VetBooks.ir
































                           FIG. 14.7  Antigen-presenting cells and helper T cells engage in a
                              dialog. Thus binding of antigen to the TCR causes the T cell to
                           express CD40 ligand (CD154). This engages CD40 on the antigen-
                             presenting cell. As a result, CD28 and CTLA-4 are expressed on
                               the T cell, and CD80 or CD86 is expressed on the antigen-
                            presenting cell. Depending on which receptors are engaged, the T
                                          cell may be stimulated or suppressed.




               CD28-CD80/CD86 Signaling

               CD28, a receptor induced by CD40-CD154 signaling on T cells, has
               two alternative ligands: either CD80 on dendritic cells,

               macrophages, and activated B cells, or CD86 on B cells. When CD80
               or CD86 bind to CD28, signals are generated that cause the T cell, in
               turn, to express yet another receptor, CTLA-4 (also called CD152).
               CTLA-4 may bind to either CD80 or CD86. The binding of CD28 to
               its ligands amplifies the stimulus to the T cell eight-fold. CD28

               stimulation enhances the production of IL-2 and other cytokines,
               upregulates cell survival genes, promotes energy metabolism, and
               facilitates T cell division. On the other hand, when CTLA-4 binds to

               CD80 or CD86, T cell activation is suppressed. The balance between
               these opposing signals delivered to T cells through these two
               receptors, CD28 and CTLA-4, regulates the intensity of T cell
               responses. (Inhibitors of CTLA-4 enhance T cell cytotoxicity and






                                                         401
   396   397   398   399   400   401   402   403   404   405   406